Interferon regulatory factor-1 (IRF-1), a transcription regulator involved both in inducing and in mediating the effects of interferon, is encoded by a highly polymorphic gene in different ethnic populations. Some of these genetic variations have been described to be associated to disease traits in hepatitis C virus and in human immunodeficiency virus infection, including one single-nucleotide polymorphism rs2549009 within the promoter region. This study aimed at investigating the functional relevance of rs2549009 on IRF-1 transcriptional activity in peripheral blood mononuclear cells in its natural genomic environment. Haplotype-specific chromatin immunoprecipitation using antibodies directed against both the transcriptionally inactive and active RNA polymerase II (RNAPII) and allele-specific transcript quantification techniques were applied to ex vivo-derived samples from healthy heterozygous donors. Inactive serine 5 phosphorylated RNAPII was found to be preferentially bound to the rs2549009 A allele in all donors investigated. Active serine 2 phosphorylated (ser2-P) RNAPII, in contrast, was found to be precipitable, depending on the donor, preferentially either with the A or the G promoter variants or without any preference. The ratio of rs2549009 A/G promoter variants engaged by ser2-P RNAPII was closely related to the relative frequency of the respective IRF-1 transcripts, and relative allelic expression was found to be associated to total IRF-1 gene expression. These results provide evidence for a bidirectional IRF-1 gene expression imbalance that appears not to be solely controlled by rs2549009 in cis and may rely on a yet unidentified variant or haplotype or on environmental control in trans.
INTRODUCTION
Host genetic factors are supposed to play a major role in determining differential susceptibility to human infectious diseases, in particular, in genes that are involved in innate immunity (1 -3) . One example are variations in the gene encoding for interferon (IFN) regulatory factor-1 (IRF-1), a transcription factor involved both in Toll-like receptor signalling and in mediating the effects of type I IFN (4, 5) . Moreover, IRF-1 initiates IFN-g-mediated major histocompatibility complex class I antigen presentation-associated gene expression (6) . Along with various levels of IRF-1 expression regulation (5) , genetic associations with susceptibility to human immunodeficiency virus-1 (HIV-1) and hepatitis C virus (HCV) infection are described for single-nucleotide polymorphisms (SNPs) within introns 1 and 9 and a microsatellite region within intron 7 (7, 8) or further intronic SNPs and a SNP at position 2300 within the promoter region (9 -11), respectively ( Fig. 1) .
Despite convincing associations of single variations with disease traits, functionality of the single variation needs to be shown (12, 13) . A functional or regulatory SNP is defined by conferring a distinct phenotype. A functional SNP within the promoter region of a gene, for instance, might affect its transcriptional activity (12, 13) . A demanding task in the field is still how to identify regulatory SNPs within gene regulatory regions. Reporter gene assays is one approach to study the impact of allelic promoter variants on reporter gene transcription within cells that have been transfected with a respective construct. Techniques that allow assessing transcriptional activity of allelic promoter variants in their natural genomic environment, however, have been developed more recently and might be superior: haplotype-specific chromatin immunoprecipitation (HaploChIP) using antibodies directed against RNA polymerase II (RNAPII) assesses the binding of the enzyme to allelic promoter variants as a surrogate for promoter activity. By using antibodies able to distinguish between serine 5-and serine 2-phosphorylated (ser5-P/ser2-P) heptapeptide repeats in the C-terminal domain (CTD) of the catalytic subunit of RNAPII, formation of a pre-initiation complex and transcript elongation can be discriminated as two stages of the transcription cycle, respectively (14, 15) . Allele-specific transcript quantification (ASTQ), as an additional approach, allows the quantification of mature transcripts that have been generated by the two parental promoter variants (16, 17) . By comparing two alleles within single heterozygous samples rather than by comparing groups of individual samples, these techniques are more sensitive in detecting cis-acting effects, and intrinsic errors that normally occur in interindividual comparisons are reduced (17) .
This study aimed at analysing whether SNP rs2549009, which is located within the IRF-1 promoter region, confers any cis-regulatory effect on its transcriptional activity in a native genomic environment in freshly isolated peripheral blood mononuclear cells (PBMC) from heterozygous healthy blood donors by applying HaploChIP and ASTQ.
RESULTS

Determination of allele-specific promoter activity by HaploChIP
To assess IRF-1 rs2549009 allele-specific promoter activity in a native sequence environment, engagement of A and G promoter variants by RNAPII was quantified by HaploChIP.
PBMC samples from 41 healthy Caucasian blood donors were genotyped at the respective position 2300 within the promoter region of the IRF-1 gene; 16 were found to be heterozygous and 7 to be homozygous for the variant allele A. The resulting minor allele frequency (MAF) of 0.366 was close to that given by the NCBI database and genotype distribution followed Hardy -Weinberg equilibrium (HWE) (P ¼ 0.322, exact test).
To discriminate between the transcriptionally inactive and active isoforms of RNAPII, antibodies were chosen with specificity for the ser5-P and ser2-P enzymes, H14 and H5, respectively. Material from five heterozygous donors captured by these two antibodies, by a mock isotope antibody, and nonimmunoprecipitated material (input) was analysed for the relative amount of IRF-1 rs2549009 A and G allele DNA fragments by restriction fragment length polymorphism (RFLP). Non-immunoprecipitated input material and mock antibody precipitated controls expectedly showed nearly no difference in the relative amount of A and G allele DNA fragments. H14 immunoprecipitated material, however, was found to consistently contain about 1.4-fold higher amounts of A than of G allele fragments ( Fig. 2A) , implying that the transcriptionally inactive ser5-P RNAPII is preferentially bound to the rs2549009 A alleles in ex vivo-derived PBMC.
The ratio of rs2549009 A and G promoter variants in H5 captured DNA, in contrast, was found to vary reproducibly between 0.79 + 0.01 (donor #1) and 1.24 + 0.02 (donor #9) (Fig. 2) , arguing for an allelic imbalance in both directions or, in other terms, against a preferential progression of RNAPII through the transcription cycle on a particular promoter allele variant.
Relative allelic expression of IRF-1 transcripts
To address the question of whether allelic promoter activity is related to an allelic imbalance in mature IRF-1 transcripts, Figure 1 . Schematic overview of the organization and variability of the IRF-1 gene and transcript. In humans, the IRF-1 gene is located on chromosome 5. The gene and the nearby 5 ′ and 3 ′ region include 25 variant positions (marked in grey) with a MAF . 0.1 known so far for the Caucasian population (NCBI database). rs2549009 and rs839 are indicated in blue within the chromosome (A), the gene (B) and the transcript (C). The positions of genetic variations that have been shown to be associated in addition with susceptibility to HIV-1 infection (rs2070721, rs41498144, rs2070729) or to HCV infection (rs2549009, rs2070721, rs2070723, rs2070728, rs2070729, rs839) are shown in green (7, 11) .
ASTQ assays were established. Aiming at identifying a SNP within the transcript suitable for assigning promoter to transcript variants, the cohort of 41 healthy blood donors was genotyped for the SNP rs839 located within IRF-1 exon 10 as well. Genotyping resulted in a distribution identical to the rs2549009 genotypes, thus being in line with HWE (P ¼ 0.322, exact test), and a MAF of 0.366 close to that given by NCBI. Noteworthy, all individuals homozygous for the Figure 2 . Chromatin immunoprecipitation. (A) Formalin-fixed and enzymatically sheared chromatin from five healthy individuals, who are heterozygous at SNP rs2549009 and rs839, was immunoprecipitated with antibodies directed against ser5-P and ser2-P RNAPII, H14 and H5, respectively, or a mock isotype. Nonimmunoprecipitated material was used as an additional input control. Purified DNA fragments were subjected to amplification spanning a region around rs2549009 and yielding a product of 142 bp in size. Products were subjected to two different restriction enzyme digestions with MvaI and BcnI. Digestion with MvaI (indicated in red) results in fragments of 69, 49 and 24 bp in size representing A allele promoter variant, while fragments of 118 and 24 bp represent G allele promoter variant. Digestion with BcnI (indicated in blue) results in fragments of 91, 36 and 15 bp in size representing A allele, while fragments of 72, 36, 19 and 15 bp represent G allele promoter variants. Quantification of fragments was carried out in a bioanalyzer. Ratios of variant A and wild-type G allele promoter variants were calculated from the molar quantities of the respective fragments. Material from homozygous individuals (AA and GG) is shown as controls for complete and specific enzymatic activity. (B) Experiments were performed at least two times and mean ratios and standard deviations are given. In total, 12 independent immunoprecipitations were carried out on 9 independent cross-linkings of freshly isolated PBMC samples.
IRF-1 promoter rs2549009 wild-type allele G were found to be homozygous for the exon 10 rs839 wild-type allele G, too. With only two exceptions, the same was true for the variant allele A and for the heterozygous genotype findings. One rs2549009 heterozygous donor was found to be homozygous for the variant allele in rs839, while another donor homozygous for the A allele in rs2549009 showed a heterozygous genotype at rs839. On the basis of these findings, the degree of linkage disequilibrium (LD) was calculated. With a D ′ ¼ 0.947 and r 2 ¼ 0.897 the wild-type alleles G and the variant alleles A for both SNPs were shown to be in high and thus in suitable linkage for assigning transcript to the respective promoter variants.
The relative amounts of allelic transcripts in ex vivo-derived PBMC were quantified independently by two different read-out assays: (i) by 5 ′ -nuclease assays using differently labelled allele-specific probes, a method that has been validated before using genomic DNA (gDNA) and cDNA samples from individuals heterozygous at a SNP within an imprinted gene (18) and (ii) by RFLP analyses using restriction endonucleases specific for each allele and quantification of fragments with a bioanalyzer. Among 16 individuals, the rs839 A/G ratios varied between 0.84 (donor #12) and 1.13 (donor #9) (Fig. 3A) . Similar results were obtained by using RFLP analyses as a read-out with rs839 A/G ratios varying between 0.87 and 1.06. A linear regression analysis of the data derived from the two different read-out assays revealed a close correlation (P ¼ 0.003, r ¼ 0.702) (data not shown).
The relative engagement of IRF-1 rs2549009 A and G promoter variants with ser2-P RNAPII correlates to the relative allelic expression of IRF-1 transcripts
The relative proportion of allelic DNA fragments engaged by transcriptionally active RNAPII was found to be related to respective allele-specific IRF-1 gene expression: those individuals who showed a preferential occupation of the rs2549009 A or G promoter variant by the active enzyme did reveal higher amounts of rs839 A or G IRF-1 transcript variants, respectively. In detail, PBMC obtained from donor #9 had an rs2549009 A/G promoter variant ratio of 1.22 and an rs839 A/G transcript ratio of 1.13 (Figs 2 and 3) . PBMC from donors #1 and #4 with a higher promoter activity on the rs2549009 G allele in terms of a preferential binding of the active RNAPII, i.e. A/G ratios ,1, also exhibited an rs839 A/G transcript ratio ,1. Furthermore, samples from donors #8 and #10 with nearly equal activity on both rs2549009 promoter variants failed to exert any imbalance in allelic transcript expression (A/G ratios 0.98 and 0.99) (Figs 2 and 3) . A linear regression analysis revealed a close ′ -nuclease assays using allele-specific probes. Measurements were performed three times independently each in duplicates. Mean values and standard deviations are given. (B) Accuracy of allelic discrimination by allele-specific probes was assessed by mixing cDNA samples from G and A homozygous individuals at the given ratios and subjecting them to the read-out assay. Results closely met the expected ratios.
correlation between the presence of transcriptionally active RNAPII on the particular promoter variant and the amount of respective allele-specific IRF-1 transcripts (Fig. 4) .
Relative allelic IRF-1 expression is associated to total IRF-1 gene expression
In addition to the assessment of relative allelic IRF-1 expression in rs2549009 heterozygotes, total IRF-1 gene expression was quantified in freshly isolated PBMC samples as well. Data were related to glyceraldehyde-3-phosphate dehydrogenase (GAPDH) as a reference transcript. Within the group of rs2549009 heterozygous donors, total IRF-1 mRNA levels were found to be significantly and positively related to the relative amount of G allele transcripts (Fig. 5A) . A comparison of the levels of total IRF-1 mRNA between genotypic groups, in contrast, did not reveal a significant difference (P ¼ 0.2709) (Fig. 5B) .
DISCUSSION
HaploChIP and ASTQ are two techniques that enable studying the impact of genetic variants in their natural genomic context by using ex vivo-derived material. Applying HaploChIP by using antibodies directed against RNAPII, in particular those that are able to discriminate between phosphorylated isoforms (14, 15, (19) (20) (21) , the combination of both techniques is expected to allow valuable insights into the activity of allelic promoter variants.
In PBMC from healthy blood donors, ser5-P RNAPII was consistently found to be preferentially recruited to the rs2549009 A allele promoter variant indicating a stronger transcription initiation activity on the variant A than on the wildtype G promoter (Fig. 2) . Progression through the transcription cycle in terms of RNAPII serine 2 phosphorylation, however, was either more pronounced to the A or the G alleles or without any preference, depending on the donor (Fig. 2 ).
Ser5-P RNAPII has been shown to preassemble to the promoters of many mammalian genes across the genome in the absence of gene induction (22, 23) . The pre-assembled enzyme, however, fails to generate mature protein-coding transcripts (24) . Induction of gene expression was shown to be controlled at the transition from initiation to elongation by the recruitment of kinases and subsequent phosphorylation of serine 2 residues within the CTD of RNAPII (24) . We suppose that the variant A allele might be advantageous for pre-assembly and transcription initiation, but that it does not necessarily impact the transition towards transcriptional elongation in PBMC. The observation of a donor-dependent allele-specific ser5-P RNAPII activity is compatible with in vitro findings on IRF-1 promoter activity showing stronger promoter activity either by the one or the other allele depending on the system (25, 26) . Whereas Saito et al. Data on promoter activity as assessed by HaploChIP were complemented by ASTQ assessing the relative number of allelic mature transcripts originating from IRF-1 rs2549009 promoter variants (Fig. 3 ). An allelic imbalance could be demonstrated in samples from those individuals in whom a preferential engagement of the respective promoter variants by ser2-P isoform of RNAPII was observed (Fig. 4) .
This bidirectional imbalance in allele-specific transcription in rs2549009 heterozygous samples argues against a sole cisregulatory role of rs2549009 in IRF-1 gene expression. IRF-1 gene expression might be regulated either by other cis-acting elements as well or it might be subject to gene -environment interactions in trans. The IRF-1 rs2549009 SNP is in close neighbourhood to two other SNPs, rs2549007 and rs2706384, which also have been identified by Saito et al. (10) and which are located 110 and 115 nt upstream of rs2549009, respectively. The high degree of LD that has been found for the Japanese population is true for our cohort of healthy Caucasians for rs2549007, too (D ′ ¼ 1.0, r 2 ¼ 0.947) (unpublished data). Because of this high degree of LD, any observation made for rs2549009 might be attributable as well to rs2549007. Regarding rs2706384, MAF is lower in our Caucasian cohort, but allelic LD is close (D ′ ¼ 0.926, r 2 ¼ 0.604) (unpublished data). Thus, any observation made for rs2549009 might be attributable also to rs2706384, and haplotypes might have to be regarded.
An impact of environmental factors on rs2549009-dependent IRF-1 gene expression is supported by a comparison of IRF-1 gene expression and its inducibility by IFN-a in PBMC from healthy individuals and patients with chronic HCV infection. IRF-1 mRNA expression levels in ex vivoderived PBMC from hepatitis C patients were significantly higher than in healthy individuals, but neither significantly different with regard to rs2549009 genotype (27) . Responsiveness of PBMC to human recombinant IFN-a in vitro, however, was significantly higher in healthy individuals, and, among healthy individuals, more pronounced in A allele carriers than in GG homozygous (unpublished data). The finding that relative allelic IRF-1 expression is related to total IRF-1 expression suggests, however, a biological impact of rs2549009 on total IRF-1 gene expression. It is conceivable that the expression of either the rs2549009 A or the G allele gene is subject to a negative or a positive regulation in trans, respectively.
Allele-specific gene expression has been shown for up to 5% of human autosomal genes (28) . Whole genome linkage studies of total expression have suggested that 1 -3% of human genes harbour common cis-acting variants (29) (30) (31) . Functional studies on single SNPs confirmed their impact on gene expression (32) (33) (34) . Quite in accordance with our data, it also has been reported that imbalances of a particular gene may only occur in some individuals (30, 31) . The range of allelic imbalance can vary a lot not only between genes but also between individuals from less than 10% to 4.3-fold or higher (29, 30, 32, 35) .
The finding that allele-specific IRF-1 gene transcription is associated to total IRF-1 gene expression is evident only in heterozygous samples rather than becoming evident in comparing genotypic groups underscores the higher sensitivity of the in vivo approach for detecting functional cis-acting variations. Both, in HaploChIP and in ASTQ analyses, allelic promoter activity is assessed in heterozygote individual samples in a natural genomic context regardless of any trans-acting effects. However, given a sufficient enough number of samples, such a cis-acting mechanism might become apparent in the comparison of genotypic groups as well.
Interestingly, Ball et al. (7) reported on an HIV-1-resistent phenotype correlated with IRF-1 gene polymorphisms and low IRF-1 expression. Two of the variations linked to the HIV-1 protective phenotype (rs2070721, rs2070729) have also been associated to susceptibility towards HCV infection by Fortunato et al. (11) . The contribution of SNPs that are located within the promoter region of a gene to transcriptional regulation is more obvious than a contribution of a SNP which is located within an intron, for instance. Some introns, however, are known to contain enhancer elements, while others elevate mRNA accumulation by a different process that has been termed intron-mediated enhancement (IME). Although the mechanism remains to be unravelled, a model of IME has been proposed in which introns increase transcript elongation (36) . Functional analyses of further, e.g. intronic, IRF-1 gene variations together with approaches considering gene -environment interactions will enhance the understanding of the role of genetic variations for IRF-1 gene expression and their relevance for individual susceptibility to viral infections.
MATERIALS AND METHODS
Blood donors
From 41 healthy Caucasian blood donors (20 female, 21 male; mean age 31.8 years, range 23-57), samples of 30 ml venous blood were taken for genotyping and for isolation of total cellular RNA. Blood donors with appropriate genotypes were, randomly chosen and consecutively on different days, asked to give further blood samples of 30 ml for HaploChIP experiments up to three times for independent replications (n ¼ 5). All volunteers gave a written informed consent and the study was approved by the local ethical committee and conformed to the ethical principles of the 2000 Declaration of Helsinki.
Preparation of PBMC and isolation of total cellular RNA
From approximately 30 ml of heparinized peripheral blood, PBMC were prepared by Ficoll density centrifugation using guanidinium isothiocyanate, and total cellular RNA was isolated by CsCl density gradient ultracentrifugation essentially as described (37) .
Genotyping gDNA was purified from whole blood samples using the QIAamp DNA Blood Mini Kit following the blood and body fluid spin protocol (Qiagen, Hilden, Germany). Typically, genotyping was performed by using 2 -4 ng of PBMC-derived gDNA in a total volume of 10 ml in 5 ′ -nuclease real-time polymerase chain reaction (PCR) assays carried out in the sequence detection system ABI StepOnePlus according to the supplier's instructions (Applied Biosystems, Darmstadt, Germany).
Genotyping of rs2549009 was carried out by amplifying gDNA with 0.36 mM of primers each (forward 5 ′ -GGA CAA GGC GGA GTG AGA-3 ′ , reverse 5 ′ -GGC TGC CCG GGA CAG-3 ′ ) using the TaqMan Genotyping Master Mix (Applied Biosystems). Allelic discrimination was achieved by adding 0.2 mM differentially fluorescence dye-labelled allele-specific minor groove binder probes (VIC 5
. Genotyping of rs839, the marker SNP for ASTQ, was performed by using the commercially available TaqMan genotyping assay C_2554641_10.
HaploChIP
Chromatin immunoprecipitation (ChIP) was conducted using the ChIP-IT Express kit (Active Motif, Rixensart, Belgium) according to the supplier's protocol as described (18) . In brief, cross-linked and enzymatically sheared chromatin corresponding to 1 × 10 6 cells was incubated with 4 mg of antibodies directed against ser5-P (H14, Covance, California, USA) or ser2-P (H5, Covance) RNAPII (38) or an IgM-mock control antibody (Linaris, Wertheim-Bettingen, Germany) or was used as control 'input' DNA. Antibodybound protein/DNA complexes were immunoprecipitated by 25 ml magnetic protein G-coated beads that have been pretreated with 5 mg of a bridging anti-mouse-IgM antibody (Jackson ImmunoResearch, West Grove, PA, USA) for 1 h at 48C according to the supplier's instructions.
After reverse cross-linking and treatment with proteinase K, 0.4 ml of input DNA, 4 ml of anti-RNAPII captured DNA and 4 ml mock control DNA were amplified in a total volume of 50 ml by PCR using 0.30 mM of primers each (IRF rs2549 for 5 ′ -CAG GAG GGT GAA AAG ATG GCC-3 ′ , and IRF rs2549 rev 5 ′ -CGA GCG CTC CCA ATC CAC-3 ′ ). Cycling conditions were a 3 min denaturation at 948C, 45 cycles of 30 s denaturation at 948C, annealing at 608C for 30 s and elongation at 728C for 30 s each, followed by a final elongation step for 10 min at 728C. Products (142 bp) were purified and concentrated using the PrepEase gel extraction kit (USB, Cleveland, OH, USA). RFLP analyses were performed by subjecting the amplicons to restriction endonucleases digestion by MvaI and BcnI (Fermentas, St Leon-Rot, Germany) for 3 h. MvaI cleaves A allele products into fragments of 69, 49 and 24 bp in size, and G allele products into fragments of 118 and 24 bp, whereas digestion by BcnI leads to fragments of 91, 36 and 15 bp in size for A allele products and to fragments of 72, 36, 19 and 15 bp in size for G allele amplicons, respectively. To stop enzymatic digestion, reactions were cleaned a second time using the PrepEase gel extraction kit (USB) following the PCR purification protocol. Fragments were analysed in the Agilent 2100 bioanalyzer using the DNA 1000 LabChip kit (Agilent Technologies, Böblingen, Germany). The relative amounts of A and G allele products were calculated.
ASTQ
Allele-specific quantification of IRF-1 transcript variants using rs839 as a marker SNP was achieved by (i) 5 ′ -nuclease assay using two differently fluorescence dye-labelled allele-specific probes for the SNP rs839 and by (ii) RFLP analyses using two different allele-specific restriction endonucleases. Corresponding gDNA from double heterozygous samples was used as a control for both read-out assays. For 5 ′ -nuclease assay, 6.4 ng cDNA and 4 ng gDNA were amplified in realtime PCR using a commercially available TaqMan genotyping assay (C_2554641_10).
For RFLP analyses, a product of 325 bp in size was generated by conventional PCR (IRF exon 10 for 5 ′ -AGC CCA GCT GCC TGG AGA-3 ′ , IRF exon10 rev 5 ′ -GAA ATG TGG CAA GAT CCA CAC G-3 ′ ) and subjected to digestion by LweI and BseMI (Fermentas) for 3 h. BseMI cleaves A allele products into fragments of 97 and 228 bp in size, whereas digestion by LweI leads to fragments of 93 and 232 bp in size for G allele products, respectively. Fragments were purified and concentrated using the PrepEase gel extraction kit (USB) and afterwards separated and analysed in the Agilent 2100 bioanalyzer using the DNA 1000 LabChip kit (Agilent Technologies). The relative amounts of A and G allele products were calculated. Validation of used cDNA for both assays was performed by discrimination at SNP rs705 within the imprinted gene SNRPN (16) .
Quantification of IRF-1 mRNA
Quantification of IRF-1 gene expression was performed by real-time RT-PCR using the sequence detection system StepOnePlus (Applied Biosystems) as described (37) . Commercially available TaqMan gene expression assays were used for the determination of IRF-1 (Hs00233698m1) and GAPDH (Hs99999905m1) transcripts.
Statistical analysis
Total gene expression analyses of 41 healthy blood donors with regard to promoter SNP genotypes were determined using one-way ANOVA (Kruskal -Wallis test) by applying the software GraphPad Prism version 4.00 (GraphPad Software Inc., La Jolla, CA, USA). Correlation and linear regression analyses were also performed using GraphPad Prism version 4.00. P-values , 0.05 are considered significant.
The degree of LD, expressed as D ′ and r
2
, between observed and expected frequencies of rs2549009/rs839 haplotypes and exact test for HWE were assessed by HaploView version 4.1 (39) .
